Legend: 
= Applied Session,
= Theme Session,
= Presenter, Sheraton Seattle Hotel & Towers = “S”
Washington State Convention & Trade Center = “CC”, Grand Hyatt Seattle = “H”
|
|
|
|
|
249
|
Tue, 8/8/06, 8:30 AM - 10:20 AM
|
CC-610
|
|
Design of Power and Sample Size in Clinical Trials - Contributed - Papers
|
Biometrics Section, ENAR
|
|
Chair(s): James F. Ward, Sand Point Statistics Group
|
|
8:35 AM
|
Blinded Sample-Size Re-estimation in Randomized Block Trials with Continuous Endpoint —  Biao Xing, Genentech, Inc.; Jitendra Ganju, BiostatWorks
|
|
8:50 AM
|
Sample Size Re-estimation for Time-to-Event Studies — Erinn Hade, The Ohio State University; Soledad Fernandez, The Ohio State University; David Jarjoura, The Ohio State University
|
|
9:05 AM
|
Sample Size and Power Calculation with Generalized Mixed Effects Model — Qianyu Dang, University of Pittsburgh; Sati Mazumdar, University of Pittsburgh
|
|
9:20 AM
|
Design of Clinical Trials with Flexible Sample Size — Lu Cui, sanofi-aventis; Fang Liu, Merck Research Laboratories; Ray Zhu, sanofi-aventis
|
|
9:35 AM
|
Approximate Confidence Intervals for Power in UNIREP Analyses — Matthew Gribbin, The University of North Carolina at Chapel Hill; Keith E. Muller, The University of North Carolina at Chapel Hill; Jacqueline Johnson, The University of North Carolina at Chapel Hill
|
|
9:50 AM
|
Designing Standardly Tailored Multicomponent Intervention Trials in Medicine To Yield Unbiased Effect Estimates — Heather G. Allore, Yale University
|
|
10:05 AM
|
Evaluation of Several Multiple Comparison Procedures for Noninferiority Trials with Two Doses of a Treatment and a Control with a Binary Success Rate Endpoint — Hongling Zhou, U.S. Food and Drug Administration; Mohammad Huque, U.S. Food and Drug Administration
|
| |
